Creepy Crawlies on Your Lids: The Truth About Demodex Mites
'Demodex mites, often called 'eye bugs,' are microscopic parasites that inhabit the sebaceous glands and hair follicles of the eyelids,' explains Dr Bhanu Prakash, senior consultant, cataract, cornea, and refractive surgeon at Yashoda Hospitals, Hitec City. 'Though they're a natural part of the skin's ecosystem, problems begin when their population grows out of control, leading to a condition known as Demodex blepharitis,' says Dr Bhanu.
According to Dr Deepti Mehta, senior ophthalmologist at CARE Hospitals, Hitec City, 'These mites feed on dead skin cells and oils around the lashes, which can result in symptoms like redness, itching, watering, a gritty sensation, and crust formation at the lash base. Left untreated, the condition can lead to blocked oil glands, misdirected lashes, eyelash loss, severe dry eyes, and even ulcers on the eye surface.'
Dr Bhanu further warns, 'In severe cases, untreated infestations can cause permanent scarring or even vision loss, especially in people with underlying skin conditions like rosacea.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
3 days ago
- New Indian Express
Supporting mothers beyond feeding
For most new mothers, the early days of motherhood can feel like a blur, marked by sleepless nights, hormonal upheavals, and a rollercoaster of emotions that rarely make it to the baby books. While breastfeeding is often idealised as a natural and beautiful bonding experience, the reality can be far more complex. It can feel overwhelming, isolating, or even distressing. As World Breastfeeding Week (August 1–7) is observed globally, experts speak to CE about the intersection of breastfeeding and mental health, addressing postpartum depression, anxiety, and the emotional toll of nursing. 'Fatigue and emotional ups and downs are common during the postpartum period,' says Dr Pallavi Chandra Ravula, consultant obstetrician and HOD of obstetrics at Fernandez Hospital, adding, 'However, when a new mother experiences a persistent low mood, guilt, anxiety, difficulty functioning, or disinterest in the baby over a long period, it isn't just exhaustion — these symptoms can indicate postpartum depression or anxiety.' While breastfeeding is known to release oxytocin, often called the 'love hormone' which promotes calm, reduces stress, and enhances bonding, it's not a universally calming experience.
Time of India
31-07-2025
- Time of India
No Radiologist, No Problem: Qure.ai's AI Takes the X-Ray Lead
By Staff When Prashant Warier co-founded nearly a decade ago, artificial intelligence in healthcare was largely experimental. Today, the company's AI algorithms are helping interpret millions of medical images each year — and in some countries, replacing the need for human readers in critical a conversation with ET Studios' Tech Heal moderated by Shilpa Rathnam, Warier, CEO of traced the company's origins to a specific gap in healthcare: chest X-rays — the most common and oldest form of medical imaging — were often not being read by radiologists. In India and other parts of the world, general practitioners or technicians often handled interpretation. In some cases, patients received no report at all. set out to automate that process, training AI models on a large volume of de-identified clinical images sourced through hospital partnerships. The company now works with over 100 healthcare institutions globally and has built a dataset exceeding 1.5 billion images. The company's flagship product, qXR, is a tool designed to detect abnormalities in chest X-rays — including signs of tuberculosis — in under 30 seconds. The tool is currently deployed in screening programs across several countries, including the Philippines, where mobile vans equipped with X-ray machines use qXR to produce real-time readings. Before deployment, such scans could take weeks to be interpreted. In 2021, the World Health Organization formally endorsed solution as an autonomous tool for TB detection, without the need for human review. Warier describes this as a key inflection point for the company. It is also now the most scaled use-case of autonomous AI in healthcare , with the system analyzing between 5 to 10 million X-rays annually. path to adoption has not been without challenges. AI used in clinical pathways is considered a medical device, which means every deployment must go through rigorous regulatory approval. The company spent three years obtaining its first FDA clearance in the U.S. and now holds 18 regulatory approvals, including CE certification in Europe. Each submission typically requires data from the local population and independent comparison against certified radiologists. Warier emphasizes that the role of AI is not to replace physicians but to support them. While automation can handle high-volume, routine imaging, tasks like diagnosis confirmation, treatment planning, and patient communication remain with clinicians. 'AI will be there throughout the patient journey,' he says, 'but it will be an assist.' Looking ahead, Warier expects AI to take over more foundational tasks in radiology — flagging abnormalities, creating template reports, and improving scan-to-diagnosis times. As India's digital health infrastructure evolves — particularly with the introduction of personal health IDs and medical data interoperability — Warier believes the accuracy and value of AI in healthcare will continue to rise. is currently active in 90 countries, with a growing presence in low- and middle-income regions where radiology expertise is scarce. The company's approach, Warier says, remains grounded in utility: 'We started by solving a problem nobody else was looking at.' Disclaimer - The above content is non-editorial, and ET Healthworld hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.
New Indian Express
30-07-2025
- New Indian Express
Ayurveda, reinvented for today
At a time when wellness often swings between traditional remedies and high-tech solutions, Hyderabad-based 365veda emerges with a quiet revolution, one that respects the depth of Ayurveda while embracing the precision of modern science. CE sat down with Harshit Gohil, co-founder of 365veda, to understand what sparked this journey, the challenges along the way, and how 365veda is reshaping the wellness narrative through their pioneering Ayurceuticals. Excerpts What inspired you to launch 365veda? The idea for 365veda was born out of a deep respect for Ayurveda and a realisation that its everyday relevance could be amplified through science and innovation. My exposure to the field began early on, as I was closely involved in growing our family's Ayurvedic business, Gohil Ayurved, which had a wide distribution network across East India. That experience gave me a front-row seat to the enduring trust people place in Ayurveda and the systemic limitations that have prevented it from being a part of modern wellness routines. While Ayurveda has always been valued for long-term health, I saw an opportunity to make it more accessible, faster-acting and aligned with today's priorities. With 365veda, the goal wasn't to reinvent the tradition but to reintroduce it in a way that speaks to modern consumers through well-researched formulations, convenient formats, and measurable outcomes. That's how the idea of Ayurceuticals came to life. How has your journey been so far? Intense, unpredictable, and incredibly educational. From the outside, entrepreneurship often looks glamorous, but the reality is a long game of resilience, adaptation and constant learning. The real reward is hearing from someone who's sleeping better, feeling more energised, or trusting Ayurveda again because of something we built. That's what makes this journey meaningful.
